DePinho Sole Finalist for President
Volunteer Voice - Spring 2011
The University of Texas System Board of Regents has named Ronald A. DePinho, M.D., as the sole finalist for the presidency of MD Anderson Cancer Center.
DePinho is the director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute and professor of medicine (genetics) at Harvard Medical School. DePinho, a member of the Institute of Medicine of the National Academies and fellow of the American Academy of Arts and Sciences, previously held numerous faculty positions at the Albert Einstein College of Medicine in New York.
He will succeed John Mendelsohn, M.D., who announced last December his plans to step down as president once his successor is in place. Mendelsohn has served as MD Anderson's president for the past 15 years.
"Dr. DePinho is a distinguished scientist and proven administrator capable of leading the nation's premiere comprehensive cancer center, UT MD Anderson. He has an excellent background in teaching and research and a demonstrated ability to work effectively within complex medical institutions," Regents' Chairman Gene Powell said. "The board is extremely confident he has the ability to advance the institution's mission in "Making Cancer History," Powell added.
Read the full news release from the UT System.